Aprameya EngineeringNSE:APRAMEYA -1.15%41 Gross Margin % is 44.59% as of Mar. 2026, which is 60% above its 10-year median of 27.88. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Aprameya Engineering ranks worse than 62.36% on this metric.
The historical rank and industry rank for Aprameya Engineering's Gross Margin % or its related term are showing as below:
NSE:APRAMEYA'
s Gross Margin % Range Over the Past 10 Years
Min: 22.97 Med: 27.88 Max: 44.6
Current: 44.6
During the past 7 years, the highestGross Margin % of Aprameya Engineering was 44.60%. The lowest was 22.97%. And the median was 27.88%.
NSE:APRAMEYA's Gross Margin % is ranked worse than 62.36% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs NSE:APRAMEYA: 44.60
Aprameya Engineering had a gross margin of 44.59% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Aprameya Engineering was 8.60% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Aprameya Engineering had a gross margin of 44.59% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Aprameya Engineering Gross Margin % Related Terms
Aprameya Engineering Gross Margin % Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Aprameya Engineering (NSE:APRAMEYA) has a Gross Margin % of 44.59% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Aprameya Engineering and its competitors. This is 60% above median its historical median of 27.88. Over the past decade, Aprameya Engineering's Gross Margin % has ranged from 22.97 to 44.60. According to the industry distribution chart, Aprameya Engineering ranks #502 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 62.4%.
Is Aprameya Engineering's Gross Margin % too high?
Aprameya Engineering's current Gross Margin % of 44.59% is 60% above median its 10-year median of 27.88. Over the past 10 years, this metric has ranged from a low of 22.97 to a high of 44.60. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Aprameya Engineering's value of 44.59% is 14.2% below this industry median. Based on the distribution chart, Aprameya Engineering ranks #502 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #502 out of 805 companies for Gross Margin %. This places Aprameya Engineering in the lower half of its industry. The industry median Gross Margin % is 51.94. Aprameya Engineering's value of 44.59% is 14.2% below this benchmark. Historically, Aprameya Engineering's own Gross Margin % has ranged from 22.97 to 44.60 over the past decade. While the company's 10-year median is 27.88 vs. the industry median of 51.94, Aprameya Engineering has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current Gross Margin % of 44.59% is 14.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current Gross Margin % is 44.59%, which is 60% above median its own 10-year median of 27.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current Gross Margin % of 44.59%. The current Gross Margin % is 44.59%, which is 60% above median its 10-year median of 27.88 and 14.2% below the Medical Devices & Instruments industry median of 51.94. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current Gross Margin % is 44.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score
Get the complete analysis for NSE:APRAMEYA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 